Interestingly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), used in the treatment of T2DM and obesity, are known to show pro-cognitive and neuroprotective properties, and exert modulatory effects on immune, endocrine and metabolic processes in the central nervous system
The meals in this plan are built to be gentle enough that most of them work on sensitive days, but give yourself permission to simplify even further when you need to
32 Shor et al used a nationwide Canadian EHR database to compare 46,334 patients taking GLP-1 RAs with 92,668 controls over a follow-up period of 6 months to 3 years
The companys website claims that this route of administration has better bioavailability and a quicker onset of action than traditional oral pills. It is unclear what scientific evidence these claims are based on
And ask them questions like, is my weight affecting my health
About the Author Dr